Futuregrowth’s Development Equity Fund (DEF) has invested in South African company hearX – a disruptive, early-stage medtech company.

The hearX Group was established in 2016 by Pretoria-based academics and still operates from there. Though still an early-stage investment for DEF, hearX has conducted over one million hearing tests and screenings worldwide since its inception. Its products are now used in over 68 countries. The company’s vision is to provide affordable and acc...